100.36 Ischemic Versus Bleeding Risk Consideration for the Duration of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Interventions
Titel:
100.36 Ischemic Versus Bleeding Risk Consideration for the Duration of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Interventions
Auteur:
Gajanana, Deepakraj Rogers, Toby Iantorno, Micaela Weintraub, William Shlofmitz, Evan Khalid, Nauman Chen, Yuefeng Torguson, Rebecca Khan, Jaffar Musallam, Anees Ben-Dor, Itsik Satler, Lowell Waksman, Ron